Catalyst Wire Dossier Catalyst Wire Dossier

Ologen (OculusGen)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ologen (OculusGen), covering 2011-10-07 to 2017-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Ologen (OculusGen)-Glaucoma Case Control Trial in India [Phase 3]

See pricing